Dr Doraid Alrifai is an experienced medical oncology physician who manages patients with thoracic (lung, mesothelioma, thymoma) and urological (kidney, ureter, bladder, prostate, and penile) malignancies. Dr Alrifai graduated from the University of Birmingham Medical School in 2007 and has trained at leading academic institutions such as University College London Hospitals and Guy’s and St Thomas’. He has extensive experience in early and late-phase clinical trials, serving as a principal and sub-investigator on numerous oncology studies. Dr Alrifai holds an MSc from the Institute of Cancer Research and a PhD focusing on thoracic malignancies from University College London. He has published in prestigious journals, including the New England Journal of Medicine, and contributed to oncology-based textbooks. Dr Alrifai has won national and international prizes for his work and is heavily involved in teaching, mentoring, and chairing educational and charity events. His expertise includes thoracic malignancies, urological malignancies, clinical trials, and cancer treatment during the COVID-19 pandemic.